Hanaa Soliman
Psychiatry · Long Beach, CANPI 1689643504
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,430 and has fallen 94.7% since, to $130 in 2021.
Across 170 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$448
- AbbVie$410
- Johnson & Johnson$377
- Sunovion Pharmaceuticals Inc.$371
- Neurocrine Biosciences, Inc.$235
- Vanda Pharmaceuticals Inc.$235
- plus $990 from 14 others
What the payments were for
- Food & beverage$3,058100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $448 |
| AbbVie | 33 | $410 |
| Johnson & Johnson | 14 | $377 |
| Sunovion Pharmaceuticals Inc. | 28 | $371 |
| Neurocrine Biosciences, Inc. | 12 | $235 |
| Vanda Pharmaceuticals Inc. | 9 | $235 |
| Teva Pharmaceuticals USA, Inc. | 10 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $165 |
| Lundbeck LLC | 6 | $133 |
| Alkermes, Inc. | 6 | $122 |
| Ironshore Pharmaceuticals Inc. | 5 | $83 |
| Bausch Health US, LLC | 3 | $58 |
| Indivior Inc. | 3 | $55 |
| Neos Therapeutics, LP | 2 | $39 |
| Brainsway USA Inc | 1 | $36 |
| Adlon Therapeutics L.p. | 2 | $35 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,066 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Long Beach
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.